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ABSTRACT
Congenital heart defects (CHDs) are one of the most prevalent types of birth defects in the
United States. Both environmental and genetic components are known to contribute to the
development of CHDs. One of the ways toxins present in the environment cause CHDs is by
disrupting the expression of genes known to be vital in normal cardiac morphogenesis. Thus, the
identification of both toxins that cause birth defects in cardiac development and genes expressed
during heart development is crucial in order to fully understand the relationship between
environment and genetics as they relate to CHD. Due to their external development, high
fecundity, and knowledge of their genome sequence, zebrafish are an excellent model organism
in which to study both gene expression and the role of toxins in cardiac development. Further,
many zebrafish genes are orthologous to those found in humans, and thus allow genetic findings
in zebrafish to be extrapolated to research on human disease and physiology. In order to identify
genes expressed in the heart during development a single-cell RNA sequencing (scRNAseq)
study was performed by the Bloomekatz laboratory, which preliminarily identified a novel gene
ccdc141 (coiled-coil domain containing 141) as having a role in cardiac development and
possibly CHDs. Here, we have sought to validate these preliminary studies by determining the
spatial and temporal gene expression of ccdc141 throughout the early stages of zebrafish
development. In situ hybridization (ISH) procedures utilized for this purpose are ideal for
visualizing gene expression as the entire organism can be viewed at once. Our hypothesis is that
ccdc141 will be expressed in the heart of developing zebrafish. Results obtained through ISH
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show that ccdc141 is expressed in the heart and in cardiac precursors, as well as in somites and
the head. These data will aid in further studies to determine the function of ccdc141 in
development. In addition to our work on identifying the gene expression of ccdc141, we created
an extensive table of environmental toxins that disrupt cardiac development in zebrafish and may
contribute to the pathogenesis of CHD in humans.
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INTRODUCTION
Congenital heart defects (CHDs) are one of the most common forms of birth defects,
affecting approximately 1% of live births and are a leading cause of infant mortality (5). Defects
in the heart valves and septa formation, aortic and pulmonary stenosis, and Tetralogy of Fallot
are a few examples of the different types of congenital heart defects, all of which can cause
lifelong problems for patients (5). Oftentimes, if the birth defect is not severe enough to cause
immediate problems at birth, it is not discovered until later in the child’s life when further
medical problems arise (6). Typically, patients experience pain or breathlessness during exercise,
abnormal heart sounds, and fatigue, but all of these symptoms are nonspecific and could be the
result of any number of other diseases, making CHD difficult to diagnose (7). This study seeks to
analyze gene expression and exposure to environmental toxins in zebrafish as a first step towards
a better understanding of the causes and mechanisms of CHDs in humans.
In order to determine the etiology of CHD, it is necessary to analyze the expression of
genes that play a role in cardiogenesis. Gene expression is the foundation of development and
cellular differentiation as different genes are regulated (turned on or off) based on the needs of
the cell during different stages of development or in response to environmental factors, including
environmental toxicants. Thus, the study of gene expression is vital in determining the etiology
of diseases, including CHDs. Results collected from studying how and when a gene is expressed
in normal development can be used as a control when looking at gene expression and function in
diseased cells (8). By comparing the temporal and spatial gene expression patterns of a diseased
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cell to that of a developmentally normal cell, we can identify which specific gene(s) of the
diseased cell are incorrectly regulated and thus causing disease – an important step toward
determining the function of the gene and ultimately new treatments and cures, like genetic
therapies (9, 10).

I. Zebrafish as Model Organism
A model organism is one that can be used to study a wide range of biological disciplines
(11). They are well studied organisms that are easily manipulated and maintained in a laboratory
setting and offer the benefit of having gene orthologs in other species (12). In particular, model
organisms are good for studying the molecular underpinnings of human physiology that cannot
be sufficiently studied due to ethical or practical considerations. Model organisms are essential in
biological research and offer a wealth of information, from which experimental results can be
extrapolated to other species.
Zebrafish (Danio rerio) are a particularly valuable model organism for studying a variety
of subjects, from fundamental biological processes such as gene expression, to modeling
clinically relevant human diseases. Importantly, the entire genome of zebrafish has been
sequenced, facilitating the study and identification of genes and genetic mutations. Zebrafish are
orthologous to a variety of other organisms, including humans, in which around 70% of genes
have a zebrafish ortholog (12). ccdc141, the gene of interest in this experiment, is one of those
orthologs. Thus, the function of particular genes whose function in other organisms is unclear
can be studied in zebrafish (13). Orthologous genes can be manipulated and mutated to observe
how physiological, developmental and cellular processes in zebrafish are affected; these results
can then be extrapolated to humans. This is particularly important in this study, as the main goal
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is to determine the expression of ccdc141 in zebrafish, a crucial first step in determining its
function(s) in human development.
Zebrafish embryos have other unique characteristics that make them ideal model
organisms. Principally, zebrafish embryos are transparent and undergo external development,
allowing tissue structures, gene expression, and other processes to be easily observed (14). It also
allows the researcher to easily access the embryo for genome manipulation and for live imaging.
External development allows for the study of development immediately following fertilization
and throughout development, since development occurs outside of the mother, a significant
aspect not afforded by other species. Further, zebrafish have high fecundity, and thus are able to
produce large numbers of embryos at once, providing more material for study, as opposed to an
organism that produces only one or two embryos at a time (14). Hundreds to thousands of
zebrafish can be stored in one room, saving both space and money. Lastly, zebrafish have a very
quick maturation period, allowing us to observe embryonic development in its entirety much
more quickly than could be done with organisms that take weeks or months to fully develop,
again saving both time and money (14).
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Figure 1. Stages of zebrafish development highlighted in this study. At 50%
epiboly, the animal and vegetal poles are 50% covered by the blastoderm, which is
uniform in thickness. Epiboly, the movement of blastoderm cells as they surround
the yolk and enclose the blastopore then occurs, completely covering the yolk by the
bud stage (as indicated by the prominence of the tailbud.) At 3 somites (s) stage, the
somitic furrow has formed and the polster, the hatching gland rudiment underlying
the forebrain, is prominent. In the 10s stage, the otic placode and trunk somites are
visible. Linear heart tube elongation and initiation of a heartbeat are characteristics of
26 hours post fertilization (hpf), as well as pigmentation of the skin and retina.
Motility begins at 36 hpf, and the atria and ventricle become distinct; cardiac looping
is also occurring. By 48 hpf, the pectoral buds are elongated, heart looping is
complete, and coordinated contraction of the two heart chambers begins. Adapted
from (4).
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II. ccdc141
Congenital heart diseases have a well-known genetic component – babies are more likely
to be born with a heart defect if the mother or another member of its immediate family also
suffers from a CHD (7). ccdc141 (coiled-coil domain containing 141), a protein coding gene
located on chromosome 9 of zebrafish, could be one of the genes involved in the development of
CHDs. ccdc141 was identified through the single cell RNA sequencing (scRNA-seq) of mouse
mesoderm cells, including progenitors and differentiated cardiomyocytes. A t-distributed
stochastic neighbor embedding (t-SNE) visualization of this data clusters cells with similar gene
expression patterns closer to one another and farther away from cells with varying gene
expression (Figure 2A). Clusters 1 and 2 are the clusters of cardiomyocyte cells. Analysis of
genes expressed in these clusters identified ccdc141 as a gene highly expressed in these clusters
and not in the other clusters.
ccdc141 has previously been implicated in the regulation of heart rate (15, 16). A
genome wide association study identified five previously unknown loci associated with heart rate
regulation including ccdc141 (15). Observed via electrocardiogram (ECG), results showed that
the associated SNP allele ‘A’ close to ccdc141 is associated with a prolonged QRS duration,
which slows the spread of ventricular depolarization, and increased heart rate. In fact, individuals
with the associated SNP allele showed the highest increase in heart rate of all alleles identified
(15).
Additionally, ccdc141 is has been shown to be involved in cellular migration in the
nervous system, where the gene is heavily expressed. Due to this expression pattern, several
studies have been conducted to determine the role of ccdc141 in development and disease of the
nervous system in humans. Mutations in cdc141 have been identified in the development of
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hypogonadotropic hypogonadism, a disease characterized by the dysfunction of the gonads (17).
In this disease, ccdc141 reduces the movement of migrating GnRH neurons, impairing
gonadotropic releasing hormone (18).
The preliminary data described above regarding the role of ccdc141 in the heart indicates
that ccdc141 variants/mutations could be involved in the development of CHDs. Based on these
data, we will examine the dynamics of ccdc141 expression in an attempt to shed further light on
its function in the heart and its possible role in CHD. Use of the zebrafish ccdc141 gene is ideal
in this study, as it is orthologous to the human ccdc141 gene; therefore, data collected regarding
the function of ccdc141 in zebrafish will likely be applicable to humans.
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Figure 2. t-distributed stochastic neighbor embedding (t-SNE) plot of ccdc141. t-SNE is
a dimensionality reduction algorithm mapped in two dimensions on a scatter plot. It is used
in single cell RNA-seq to visualize similar groups of cells. Each dot represents a single cell,
and cells are grouped together based on their transcriptional profiles. Cells with similar
profiles, or similar gene expression, are grouped together into clusters, and the closer the
clusters are to one another, the more similar their transcriptional profiles as well. A) Clusters
of all cell types in mouse. Clusters are differentiated by number and color as noted in the
legend. B) Range of expression of ccdc141 in the clusters. As the cell colors move from red
to magenta (range 0-26) as shown in the figure legend, the expression of ccdc141 in those
cells increases. It is highly expressed in clusters 1 and 2, corresponding to cells of the heart,
indicated by arrows. Adapted from (2, 3).
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Figure 3. Location of ccdc141 on chromosome 9 of zebrafish. ccdc141 is located
between 43,074,531 and 43,142,636 bp on chromosome 9, immediately downstream
of sestd1 and upstream of ttn.2. The direction of the arrows indicates the direction of
the genes on the reverse DNA strand. 3 isoforms are indicated for ccdc141: ccdc141201, ccdc141-202, ccdc141-203 with 25, 4, and 2 coding exons, respectively.
Adapted from https://zfin.org/action/mapping/detail/ZDB-GENE-081104-472
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III. Toxicology
Maternal exposure to environmental chemicals while pregnant, particularly in the first
trimester, has been shown to increase the risk of CHDs in their children (7). Thus, both genetics
and environmental factors contribute to cardiac developmental disruptions and CHDs. Chemicals
and toxins present in the environment can affect gene expression by interrupting biological
processes like DNA methylation, leading to defects in heart formation (19). Man-made
contaminants are ubiquitous within our environment, deriving from a variety of origins including
the burning of fossil fuels and organic matter, incomplete combustion of crude oil and coal, and
insecticides and pesticides (20-24). Furthermore, they are often composed of multiple different
components. For example, pesticides, insecticides, and herbicides are composed of compounds
like carbaryl, glyphosate, and 2,4-dichlorophenoxyacetic acid (25, 26); emissions from
automobiles and the burning of fossil fuels are composed of huge amounts of CO2 and other
compounds with multiple 6-membered carbon rings such as benzo-a-pyrene and phenanthrene
(23, 27). However, the role of these chemicals in affecting cardiac development in both fish
populations and in the human population is unknown. Similarly, it is unknown whether particular
chemicals within a mixture disrupt cardiac development or whether disruption is a result of a
combination of chemicals. Due to its high genetic and physiological conservation with humans
and its external fertilization and development, zebrafish are a good model in which to investigate
these questions. The ability to manipulate the zebrafish genome also make it a good model in
which to determine the molecular and cellular processes disrupted by chemicals, which lead to
these physiological defects. As an initial step towards the elucidation of these molecular
pathogenic pathways, I conducted a literature search compiling a table (Table 1) of chemicals
and toxins which cause cardiac defects in zebrafish embryos.
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METHODS
I. In situ hybridization
Ia. Collection and Preparation of Embryos
Prior to beginning in situ hybridization, wild type (wt) embryos at the developmental
stages 50% epiboly, bud, 3s, 10s, 26 hpf, and 36 hpf were collected. Two wt parents of the same
line and equal size were transferred to a breeding tank with a divider placed between the fish.
The tanks were then left overnight, and the divider was pulled the following morning at
“daylight,” around 8 am. To ensure time and stage of development, embryos were collected 1
hour later, placed in a petri dish with blue water, and left in the incubator at 28ºC to continue
development.
When the embryos reached the desired stage of development, the chorions of the embryos
at stages 24 hpf+ were removed (embryos <24 hpf were dechorinated post fixation in
paraformaldehyde (PFA)) and embryos were placed in 1.5 mL centrifuge tubes. Next, the
embryos were fixed in 4% fresh PFA overnight at 4ºC. The following day the embryos were
dehydrated by washing sequentially in 25%, 50%, 75%, and two times in 100%
MeOH/phosphate buffered solution/.1% tween (PBT) solutions for 10 minutes per solution
before being placed in a 1.5 mL tube containing 100% MeOH and stored at -20ºC until needed.

Ib. Permeabilization
In preparation for ISH, two tubes of approximately 10 embryos per developmental stage,
one for the control probe and one for the experimental, were rehydrated sequentially in 75%,
50%, 25% MeOH/PBT for 5 minutes per solution then washed 4x in PBT for 5 minutes at room
temperature. Next, proteinase K (PK) was added to the embryos to digest the embryos so that the
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RNA probe can enter the tissue and bind to ccdc141. PK at 10ug/ml was added to embryos at
stages 24 hpf+. Embryos were left in PK for different times based on the stage of development: 5
minutes for 24 hpf embryos or 10 minutes for 36 hpf embryos. Embryos <24 hpf were incubated
in 5 ug/ml PK for 4 minutes. After the addition of PK, embryos were rinsed twice in PBT to
remove excess PK and fixed in 4% PFA for 20 minutes at RT. Then they were again rinsed with
PBT 5x for 5 minutes per wash at RT.

Ic. Hybridization
After permeabilization by PK, embryos underwent prehybridization for 3 hours at 70ºC in
65% hybridization solution/PBT (hyb). The hybridization solution contains 50% formamide, 5x
SSC, 500µg/ml yeast RNA, 50 µg/ml heparin, 0.1% Tween, and 9 mM citric acid. Following
that, 7 µL of both the ccdc141 and myl7 probes were added separately to 200 µL 100% hyb and
incubated for 20 minutes at 70ºC; the ccdc141 probe was then added to one tube of embryos and
the myl7 probe was added to the other. Next, the embryos were hybridized overnight 16-24 hours
at 70ºC.

Id. Probe Detection [blocking/antibody binding]
In preparation for blocking and antibody incubation, the hybridized embryos underwent a
series of washes in the following order at 70ºC for 15 minutes each: 75% hyb/25% 2x salinesodium citrate (SSC); 50% hyb/50% 2x SSC; 25% hyb/75% 2x SSC; and 2x SSC. Next, the
embryos were washed twice for 30 minutes in 0.2x SSC at 70ºC. Following that was another
series of washes performed in the following order for 5 minutes each at RT: 75% 0.2x SSC/25%
PBT; 50% 0.2x SSC/50% PBT; 25% 0.2x SSC/75% PBT, 100% PBT. Embryos were then
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blocked in a blocking buffer, which contains 5 mL PBT, 2mg/ml BSA, and 5% (0.25 mL) sheep
serum, for 1 hour at RT. Next, 100 µL of the antibody anti-DIG-fab at a 1:5000 concentration
was incubated in blocking buffer overnight at 4ºC. Digoxigenin and anti-DIG-fab were used as
the label and antibody, respectively, because these have high specificity and reduce background,
making them ideal for in situ hybridization (sigma).

Ie. Staining and Imaging
For the final stages of ISH, embryos were washed 6x for 15 minutes in PBT/BSA and
then washed 3x with alkaline phosphatase buffer (NTMT) for 5 minutes. NTMT (an acronym of
the first letter of the 4 ingredients) is a staining buffer containing 0.1M NaCl, 0.1M Tris-Cl,
0.05M MgCl2, and 0.1% Tween. Embryos were transferred to clean staining dishes in NTMT
and a staining solution was added to each well, followed by incubation in the dark at RT.
Staining was checked every hour. Once the staining had developed and darkened, the embryos
were then stopped via rinsing in NTMT and fixed in 4% PFA overnight at 4ºC. The next day,
embryos were cleared by washing 5x in PBT/BSA for 5 minutes and then a 2x wash in MeOH
for 5 minutes. After the washes, the embryos were incubated in MeOH at RT for 1-several hours.
Lastly, Benzyl Benzoate:Benzyl Alcohol (BB:BA) clearing solution was added to the embryos
for imaging via bright field microscopy.
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GGTGACTTCCATCCTGACCATACATCAAGGTCAGTGCCGTGGTGACTTCCATCCTGACCA
TCTCACAGAGGAATCATTCTCCAATGACGAATACGAATGCACTTCTCCAGATGACATCT
CTCTGCCTCCTTTATCCGAGACCCCAGAATCCAACATTATCCAGTCCGAAAATGACTTTG
ATGATGGTTATTGTGTGAGCTCGCACAGCCATCGCATAAACCAATATAGCCACCAGTCC
CAATCCCATCATGGTGAAACCCTGCACCAGAGACAGCAGGATTGGATGTCAAGCCAGGC
TGAAGGTTACCCATCACCAACTGCTGTCATGGGGACCAAATTTAGATCAGAATCGTCCT
CCTTTGTTCAAAGCCCTCTCACTGTCCCTGCTCCTAATCTTGTTTCAAACACCATCTCCAC
TATTTTAAAGAACAAATCTGCCAACCCACCGCCATGCAGTGTCACTGAAACTCATTACTC
AGTGCATGAGAGTCATACCGAGACACAAAAGTGTGTGCATGATTCCAGTTTGGGTCAGT
CCAACGCCGTTCGGGCCAATAACACGCATGCAACCCCCACCCCATTAACAACAGAGTCA
GATCTCTGCAAGCCCACAGCCATCCGAGAGGAAATCAAGCGGGCGTCTTCCAAAAAGGT
TATGGGCAAACTAGAAAGCAACCCAGGCCCAAACTTCTCCAAACCTTTGTCTAATGCCA
CAGTAATGGAGGGCTCTCCGGTGACCCTGGAGGTGGAAGTCACTGGATTCCCTGAGCCT
ACATTAACCTGGTGGGTAGCTTATAACAAACTTGACCTATAAATGTAAACATTCTTTGCT
AATCGACCATTGCGCCCCAAGTCTAGGGGAAAACAACATGGGCATAATAAACAAAAAA
GATGGTGGATGGTGGATTTCCCAAACAAAAACAAAAAACTTATACAAAGGCTCCCCTTT
GGTCGACAACCAAATGCAGACACTCAGTTGAGTGTAACTGAACAGATTTATCATAGAAA
AAGAAAAGTAGCCATTTAAATGAGCATCTCTTTAGAGTGACCACAGGCCAAAATGACAA
ACAAAAGAATCTGCAAAGTAAATGATCTAAATAACCTAAAAACTCTTTAAAGAAAAAT
AGAGGAAGCTTATCTTCCTCCCTAAACATAAACAAAGTCAAAAGTAATCAAATTAATAG
GCAGGTCACCCATACAAGCTCAAACTCTCATTGCATGGACATTTGTACAAGACTAAAGT
TTGGTCGTTGGCTGGAGGAGTAGGAAAATCCAGGAGCTCTCCTTTCCCAGCAACCATTG
CACCACAAATGAGCTCCTAGAACTTTGCCGAAAGTTCCCCTTTATAGATCTCTGCAATCA
GCAGCCAATCAGAGCCTAGATCACATTAACATGGGAGCCTATGGGATAACACAAAAAC
AGCACATGAAAAACAACACAAGCAATGCTCAACAAAAAATAAATAAATAAACTTTAGC
AATCACATCAACAGTGAGGCTTGCTATTCATAATATAATATAATATAATATAATATAAT
ATAATATAATATAATATAATATAATATAATATAATATAATATATTTTGTGCATAACAGTT
TAAGATTTTGGGGTCATTGAAAATGTGTATTTATTTGTATTTTAATAGAAATTTTGAAAT
AAATGATTTTATCCAGCAGATTGGTTTAAATTAGTGTGATGGAAAAGGATAATTTATAA
TCCAACAAAATATTTATATTTGAAAATAAACATTTATTTTCAATTCTTCTAATTTCTTGGC
ATCAAATAGTAATGTCACAGTGTGTGCAAGATAAAAATTTAGATATTTTAACATTTATA
ATCAAATAAAATATCATCCAGAATGATGACTGCATTGGAATGGAGCAGTGACTGCTAAA
GCCTCATTATAGGAAATACATTTTAAACATTAAAAATAATTAAATGTATTAAAATCCAT
AGATATTTTCTATTTGTATAGCTTTTCTACTTTACTATAATTTTAATGAGATAAATGTTCT
TTATTTATATTGTGTATACATTTACAGTTGAATTATTGCCCTGCTGTATATTTTTCCCTGA
TTTCTGTTTATTGGAATGATTTTTTTTTCAAAACATTTCTAAACAGTTTTAATAACTCATC
TCTAATTATTTTAGCGTTACCATGATGACAGTAAATAACATTTTACTACATATTTTTCAA
GACACTTCTATACAGCTTAAAGTGACATTTAAAAGCTTAACTAGGTTATTTCGACAAGTT
GGGGTAATTAGGAAAATCATTGTGTAATAGTGGTTTGTTCTGTAGACACTCTAAAAAAA
TAGCTTGAGGGCTAATAAATTTTACCTTAAAAGTTTTTTTTTTTTTTTTTTTTTTATGAAA
AACTGCTTTTATTTTAGCTGAAATTAAAGAAATAAGACTTTCTCCACAAGAAGAAAAAA
AAAAAAAAAAAAAAAAACGTTATAGGAAATACTGTGGAAAATTCCCGGCCCTGATTAA
CATAATTTGGGAAATATTTGAAAAAAAAAAATTACAGGAGGGCTAATAATTCTGACTTT
AACTGTATGTATACATATATGTGTATGTATATACATCTAAATTGGTGGAAAATCCTCATT
ATACAAACCATTGATCGACACTGCAGTTTTTAAAGACTAATTTCACAGGATTGTTGATGT
AGATAAACACACATTTTTGTCTGTGCATGAAGGCAGAGTTGTTGAAAAAATGCAGTATT
TCATTTTAATTGTCCATTGTTTTTTCCACTGTCATGCATAGATTCCATTTATACTAACTTC
TTCATCCACATTTCCTTTAGCTAACCTTTCCATTGTATTTAACCTCAATAAGACTTTCTAC
TTTAACATTTCCTCTAATGTCTCTCTTCCATTGTGTGTGTGTATTAATGTGTGCTTATTTTG
CTGTGGTGTGATTGTGTGACATAATAATCCACTCTTTGTTTAGGTTCAAGAACGGACACA
AACTGGCCAATGATGAGCATATAGAACTGTCCCATAAAGAAGGCAAGCATGCGTTGTTC
ATTCACAGCTCTGCAGTGAGAGACTCTGGCCAATATGTGGTTACTGCCTCAAACTCAGC
CGGCACAGTGTCGTCCAGCTCCATGCTGCAGGTCAAAGGTAACGGCACTGACCTTGATG
TA

Figure 4: cDNA template probe sequence. Depicted is the complete
template probe sequence of ccdc141. The probe is complementary to
the sequence of ccdc141 and will hybridize with the DNA. After probe
hybridization, staining of the antibody bound to the probe will show the
location(s) of gene expression. Sequence from UCSC Genome Browser.
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Figure 5. Flow chart of in situ protocol. Purple boxes indicate collection and
preparation steps (IIa). Yellow boxes indicate denaturation steps (IIb). Blue boxes
indicate hybridization steps (IIc). Green box indicates blocking and antibody
detection step (IId). Orange boxes indicate staining and imaging steps (IIe). Figure
adapted from (1).
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II. Literature Search for Toxicants
For the literature search on environmental toxicants related to CHD, I used the
PubMed/NCBI database for researching, the Mendeley program for compiling the articles and
creating citations, and the ChemDraw software for creating the chemical structures shown in
Table 1 (28-30). Keywords used for the search are as follows: environmental toxins, congenital
heart defects, zebrafish toxins, embryonic developmental toxicity, and zebrafish environmental
contaminants.
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RESULTS
Part I: ccdc141 is a gene with little known function, but knowing the specific location(s) and
developmental stages during which it is expressed can help to elucidate its function. ccdc141 was
found to be expressed in zebrafish tissues that form and derive from the mesoderm germ layer,
including those ultimately giving rise to the fully formed heart and the heart itself.
Part II: We have compiled the published findings of environmental toxicants which disrupt
cardiac function in zebrafish.

Part I. In situ hybridization reveals location of ccdc141 expression in zebrafish embryos.
In situ hybridization (ISH) allows for the visualization of gene expression. Thus, we have
sought to perform in situ hybridization of ccdc141 at different stages of zebrafish development,
in order to aid in the effort of determining the functional relationship of the gene to zebrafish
heart development. We sought to analyze ccdc141 expression at the stages: 50% epiboly; bud; 3
and 10 somite stages; prim-5 and prim-25 stages; and long-pec stage of zebrafish. These stages
were chosen because they are representative of the gastrula, segmentation, and pharyngula
periods of zebrafish development. They are important periods in regard to heart development, as
the heart begins formation in the gastrula period and nearly completes formation by the end of
the pharyngula period. Cardiac progenitor cells first become evident in the 50% epiboly stage,
located on either side of the lateral marginal zone of the embryo (13). In the bud and 3s stages,
cardiac progenitor cells move dorsally toward the midline to reach the anterior lateral plate
mesoderm (ALPM) and arrive at the embryonic axis by the 10s stage (31). The heartbeat and
vascular circulation occur by the 26 hpf stage, after the fusion of the two tubular cardiac
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primordia form the definitive heart tube (31). By 36 hpf, heart looping is complete, and the atrial
and ventricular boundaries are clearly distinguished (31).

Ia. myl7 expressed in myocardial precursors and myocardium.
ISH of myl7 was used as a control because it has a well-known expression pattern in the
heart. By comparing myl7 expression to that of ccdc141, we can determine if the ISH was
performed correctly (if myl7 is expressed) or if the experiment was not successful (if there is no
expression of myl7). ISH of myl7 during cardiac looping in the 24 hpf and 36 hpf stages revealed
myl7 expression in the atrial and ventricular myocardium of the heart tube (Figure 7).

Ib. ccdc141 is expressed in tissues related to cardiogenesis as well as other tissues.
Beginning with the gastrula period, embryos at 50% epiboly exposed to the ccdc141
experimental probe exhibited expression of the gene in the yolk syncytial layer (YSL) (Figure
8A-C). The YSL is an important multinucleated extra-embryonic tissue located beneath the
cellular blastoderm. It plays a vital role in zebrafish development through its involvement in
coordinated cell movement, morphogenesis of the germ layers, specification of cell identity, and
cardiac morphogenesis (32, 33).
At the bud stage, ccdc141 appears to be expressed in the mesoderm of the embryo
(Figure 8D-F). The mesoderm is one of the three germ layers that gives rise to many structures
and tissues in the developing zebrafish, including the heart muscle.
In the 30 minutes of development after the bud stage, embryos enter the 3s stage in which
ccdc141 was found to be expressed in the polster and the paraxial, or presomitic, mesoderm
(Figure 8G-I). One of the three domains of mesoderm, the paraxial mesoderm differentiates into
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the somites, which are blocks of mesoderm that eventually give rise to a variety of vertebrate
body structures, including the dermis, skeletal muscle, cartilage, tendons, and vertebrae (34, 35).
Expression of ccdc141 in 10s embryos also was found to occur in specific types of
mesoderm: the anterior lateral plate mesoderm (ALPM) and the somites (Figure 8J-L). The
ALPM is a derivative of another of the three domains of mesoderm, the lateral plate mesoderm,
which forms progenitor cells for several tissue types, including the heart and cardiovascular
system (36).
By 22 hours post-fertilization (hpf), the linear heart tube of the zebrafish has formed and
at 26 hpf, ccdc141 expression was visualized in the somites and the atrial, ventricular, and
possibly endocardial cells of the heart tube, though it is difficult to differentiate atrial/ventricular
cells from endocardial cells at the magnifications used in this study (Figure 8M-P) (37). At this
point, the peristaltic contraction of the heart tube occurs, allowing for blood circulation.
Furthermore, this stage marks the beginning of cardiac looping, during which the linear heart
tube begins to form into an S-shaped loop. Expression in the ventricular and atrial
cardiomyocytes, somites, and head was present at 36 hpf; cardiac looping continues, and the
atrium and ventricle become distinguishable at this stage (Figure 8Q-R). (Images presented in
Figure 8A-P are unpublished data from the Bloomekatz lab, not my own, as I was unable to
image these embryos personally due to the COVID-19 pandemic. However, figures 1-7, figure
8Q and R, and table 1 are my own).
Determining the tissues in which ccdc141 is expressed at each stage was done by
comparing the shape and position of the ccdc141 expression pattern with the known shape of
those tissues as observed through brightfield microscopy or via the expression of other genes
known to be expressed in those tissues, such as myl7, which is known to be expressed in the
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cardiac progenitors within the ALPM (10s) and in the heart (22s-36 hpf). However, further
analysis such as the double fluorescent ISH is needed to definitely assign the identity of the
tissues in which ccdc141 is expressed.
By following the expression of ccdc141 from the 50% epiboly stage to 36 hpf (Figures 6,
8), we see a clear and consistent pattern of ccdc141 expression in tissues involved in cardiac
morphogenesis; thus, it follows that ccdc141 may play a role in the development of the heart in
some capacity, although further study is needed to determine its exact function.
The information on ccdc141 expression gathered from the study of these stages in
zebrafish can then be used to facilitate further research into determining the role of ccdc141 in
normal heart development and in the development of CHD in humans.
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Figure 6. Chart of ccdc141 expression in various tissues. Blue color filled cells
represent ccdc141 expression in the corresponding tissue and developmental stage.
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24 hpf

A

D

36 hpf

C

Figure 7. Images of myl7 expression in studied stages of zebrafish development.
(A-B) Expression in the atrial and ventricular portions of the heart, lateral view (A)
and anterior view (B). (C-D) Expression in the atrial and ventricular portions of the
heart, lateral view (C) and ventral view (D).
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36 hpf

26 hpf

M
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10 somite

3 somite
Bud

50% Epiboly

Figure 8. Images of ccdc141 expression during zebrafish development. (A-C)
Expression in the yolk syncytial layer (YSL), animal pole (A) and lateral (B, C).
YSL is visible through the enveloping layer (EVL) and blastoderm, which can be
clearly distinguished (B, C). YSL, EVL, and blastoderm are designated by black,
blue, and red arrows, respectively. (D-F) Expression in the mesoderm, anterior (D),
lateral (E), and posterior views (F). The blastoderm is thicker on the dorsal side of
the embryo at this stage, indicated by the arrow (D, E). (G-I) Expression in the
polster (indicated by black arrow) and paraxial mesoderm (red arrow), anterior (G),
dorsal (H), lateral (I) views. (J-L) Somites and ALPM expression, dorsal (J), lateral
(K), posterior (L) views. Bilateral ALPM expression is distinct in (J), indicated by
arrows. ALPM and somite expression are both visible in (K), and sequential blocks
of somite expression are visible in (L). (M-P) Expression in atrial and ventricular
regions of the heart, dorsal (M), lateral (N-P) views. Heart tube is visible just to the
left of the midline (M). Somites and heart tube visible (O). (Q-R) Expression in the
head, somites, and atrial and ventricular cardiomyocytes, ventral (Q), lateral (R)
views. Images A-M, O were all taken at 300x magnification. Images N, P Q, R were
taken at higher magnification. Images of A-P are Courtesy of Bloomekatz Lab, as the
COVID-19 pandemic prevented the completion of this project. Images Q, R were
taken by me.

32

Part II. Toxicology
The genetic and environmental components of CHD are highly interrelated and work in
concert during the progression of heart defects. Duration of toxin exposure, concentration of
exposure, and stage of development in which exposure occurred all affect the severity of the
cardiac phenotype. Observed abnormal phenotypes vary among the toxins, but abnormal heart
looping, ventricular abnormalities, and misplaced heart chambers are among the most common
phenotypes observed in zebrafish embryos. Here we have compiled a list of toxins identified
causing cardiac phenotypes in zebrafish embryos and we have highlighted a few more for indepth description. Although the presented toxins are known to contribute to CHD, the complete
etiology of their contribution to disease pathogenesis is still not well known and requires further
study.

IIa. Ethanol
Changes in development caused by ethanol exposure are characterized by changes in
gene expression, cell localization, and cellular adhesion, resulting in the disruption of several
stages of cardiogenesis in zebrafish, including, but not limited to, myocardial migration, heart
looping, and endocardial cushion formation (38). Both duration and concentration of exposure to
ethanol is important, as increased concentrations and increased time of exposure produce more
severe abnormalities. Short term exposure prior to cardiac specification or during myocardial
midline migration does not produce persistent or severe morphological defects. However, once
cardiac specification or myocardial midline migration is complete, short term exposure may
cause atypical heart development. Exposure over the entire course of cardiac development results
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in the most severe abnormal phenotypes, including defects of the atrioventricular (AV) valves
and abnormal heart looping (Table 1: Row 22) (38, 39).
Disruption of the expression of genes known to be crucial in cardiac development may be
the primary factor in producing these defects. Several genes, including hand2, gata5, fgf8a,
myl7, and vmhc are affected, as are the Bmp and Notch signaling gradients. In control embryos,
localization of these signaling cells is limited to the atrioventricular canal (AVC), whereas in
embryos exposed to ethanol, Notch and Bmp signaling cells were present throughout the entire
ventricle (39, 40).

IIb. Tetrachlorodibenzo-para-doxin (TCDD)
TCDD is an aryl hydrocarbon receptor (AHR) agonist. AHR mediates toxicity by
regulating the expression of genes with functions ranging from olfactory receptor to lipoprotein
lipase. Without a bound ligand, AHR resides in the cytoplasm in a complex with heat shock
protein 90, but upon binding of a ligand, like TCDD, the AHR complex undergoes a
conformational change, allowing it to translocate to the nucleus. Once in the nucleus, the AHR
complex dimerizes with aryl hydrocarbon receptor nuclear translocator (ARNT). The ARNT
heterodimer then binds to dioxin response elements (DREs) in the promoter region upstream of
AHR-responsive genes and directs their transcription (41, 42). Binding of TCDD to AHR results
in the downregulation of a group of genes responsible for cell division and growth, DNA repair,
and cell cycle regulation, known as cell cycle gene cluster (CCGC). This downregulation results
in a reduction in the number of cardiomyocytes, as well as increased expression of bmp4 and
notch1b, two genes necessary for proper heart valve formation (43, 44). Heart abnormalities
caused by TCDD are observable at 72 hpf. Abnormal heart looping, reduced ventricle size, and
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thin, elongated atrium are cardiac morphologies characteristic of TCDD exposure (Table 1: Row
38) (43).

IIc. Phenanthrene
Phenanthrene is an AHR agonist that is ubiquitous in the aquatic environment with wellknown cardiotoxic effects, including arrhythmias and disruption of the later stages of cardiac
morphogenesis by inhibiting cardiac conduction (45, 46). Phenanthrene exposure disrupts
expression of genes involved in cardiac morphology, function, and specification such as matrix
metalloproteinase-9 (MMP-9) whose expression is increased upon phenanthrene exposure,
altering the basement membrane surrounding the cardiomyocytes and disrupting cell signaling
(23). Additionally, expression of SERCA2a Ca2+ pump and its direct regulator, tbx5, are both
decreased. Calcium plays a vital role in myocyte contraction, and decreased expression of these
genes results in cardiomyocyte dysfunction (46). Morphological cardiac defects such as an
enlarged ventricle with thin ventricular wall, abnormal heart looping, and misplaced chambers
are also characteristic of phenanthrene exposure (Table 1: Row 31).

IId. Pyrene
Pyrene is a polycyclic aromatic hydrocarbon (PAH) and a weak AHR agonist (Table 1:
Row 34). Like several other toxins, the cardiotoxicity of pyrene acts in a dose-dependent fashion,
with more severe abnormalities being directly proportional to increasing concentrations of the
toxin (24). Exposure to pyrene results in the downregulation of Nkx2.5, a transcription factor
that plays an essential role in the development of the cardiovascular system and in the
differentiation of myocardial cells. Expression of bmp2b, an upstream gene of Nkx2.5, was
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downregulated as well (24). Altered expression of these genes leads to pericardial edema and
abnormal cardiac looping, along with elongated and misoriented heart chambers in zebrafish
(Table 1: Row 34).

IIe. Benzo-a-pyrene
Like several other PAHs, cardiac toxicity of benzo-a-pyrene [B(a)P] is related to AHR
binding and the disruption of gene expression. Heart abnormalities occur in a dose dependent
manner, with increasing concentration of B(a)P leading to a higher frequency of abnormal
cardiac morphologies, like pericardial edema, bradycardia, and abnormal heart looping (Table 1:
Row 8) (27). A network of genes responsible for regulating cardiogenesis, listed as follows, were
disrupted by exposure to B(a)P – the genes prox1, tbx5 and pak2a were downregulated upon
B(a)P exposure, while ahr1b, cyp1c1, cyp1a1, mmp9, prox1, tbx5, pak2a, and mmp2 were
upregulated (27). Exposure to B(a)P results in elongated hearts, a thin atrium and small ventricle,
and misplaced, non-overlapping chambers (Table 1: Row 8) (27).
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TOXICANT NAME

CHEMICAL
STRUCTURE

CARDIAC
PHENOTYPE
Tachycardia

2,2,4,4tetrabromodiphenyl ether

ORIGIN
Plastics and flame
retardants

REFERENCES
(47)

Arrhythmias

2,3,6,7tetrachlorocarbazole

Cl

Pericardial edema

Cl

H
N

Organic pollutant

(48)

Pesticide; synthetic
plant hormone

(49)

Organic pollutant

(48)

Elongated heart

Cl

Cl

2,4dichlorophenoxyacetic
acid

Pericardial edema

O
O
OH

Cl

Tachycardia

Cl

2,7-dibromocarbazole

Pericardial edema

H
N
Br

Br

Elongated heart

9-fluorenone

Bradycardia

Organic pollutant

(50)

Acrylamide

Bradycardia

Hydrogenation of
acrylonitrile

(51)

Water contaminant

(52),
(53)

Cardiomyocyte
proliferation reduced
Abnormal atria and
ventricles
Failed differentiation
of the
atrioventricular canal
Arsenic

Tachycardia

O
HO

As

OH

Abnormal cardiac
morphogenesis
O
N

OH

O
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Benzo-a-pyrene

Bradycardia

Forest fires; volcanic
eruptions; oil spills;
automobile
emissions

(27),
(54)

Pericardial edema

Insecticide

(20)

Pericardial edema

Pesticide

(21)

Pericardial edema
Abnormal heart
looping
Irregular heartbeat
Smaller ventricle
and thinner atria
Bifenthrin

F
F

Cl
O
F
O

Boscalid

Bradycardia

Caffeine

Tachycardia

Found naturally in
some plants
Can be synthetic

(55)

Camphor

Pericardial edema

Found in camphor
trees; insecticide

(56)

Bradycardia

Insecticide

(57)

Pesticide;
acetylcholinesterase
inhibitor

(58)

Carbaryl
NH

Heart malformation
O

Chlorpyrifos

O

Cl

Bradycardia

Cl
S
P

Cl

N

O

O
O
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Cyhalofop-butyl

Pericardial edema

O

F

Herbicide

(59)

Pericardial edema

Fungicide

(60)

Pericardial edema

Insecticide

(20),
(61)

Pesticide;
acetylcholinesterase
inhibitor

(58)

Chlorination of
drinking water

(62)

Bradycardia

Pesticide;
acetylcholinesterase
inhibitor

(58)

Bradycardia

Fungicide

(63)

Bradycardia

O

N
O

O

Cyproconazole

Deltamethrin

O

Tachycardia

O
Br
O
N

Decreased blood
flow
Cardiac edema

Br

Diazinon
N

N

S
P
O

O
O

Dichloroacetate

Tachycardia (<144
hpf)
Bradycardia (>144
hpf)

Dichlorvos

O
P

Cl
O

O
O

Cl

Difenoconazole

Cl

O

O
Cl

O

N

N

N
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Ethanol

Pericardial edema

Fermentation of
yeast

(64),
(45)

Plants and fruits

(65)

Herbicide

(66)

Leaves of Lawsonia
inermis; ink for hair
dye and tattoos

(67)

Petroleum refineries

(68)

Fungicide

(69)

Reduced heart size
Reduced ventricular
thickness
Abnormal heart
looping
Cardiac bifida

Glucose

Cardiac fusion
Severe arrhythmia
Myocardial
hypertrophy
Myofibril loss
Bradycardia

Glyphosate
(Roundup Ultramax)

Henna

Pericardial sac
edema
Slow heartbeat

Hydrogen Sulfide

Tachycardia (low
sulfide
concentrations)
Bradycardia (high
sulfide
concentrations)
Pericardial edema

Hymexazol

Absence of
heartbeat and blood
circulation
Bradycardia
Cardiac edema
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Nicotine

hERG blocker

Tobacco plant

(70),
(71)

Fungicide

(72)

Breakdown of
perfluorinated
chemicals (PFCs).

(73)

Burning of fossil
fuels, oil, wood, and
organic matter;
polycyclic aromatic
hydrocarbon

(23)

Pesticide

(74)

Fungicide

(75)

Tachycardia
N

High blood pressure
N

Paclobutrazol

OH

Pericardial edema
Abnormal heart
looping

N
Cl

N

Bradycardia

N

Perfluorooctanesulfonate
(PFOS)

Pericardial edema
Tachycardia (larvae)
Bradycardia
(embryos)
Heart malformations

Phenanthrene

Pericardial edema
Abnormal heart
looping
Enlarged ventricle
Thin ventricular wall
Tachycardia

Profenofos

Pericardial edema
Abnormal heart
looping
Bradycardia
Thin atria wall

Pyraoxystrobin

Pericardial edema
Bradycardia
Arrhythmia
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Pyrene

Pericardial edema

Incomplete
combustion of crude
oil and coal

(24)

Crude oil; paper
mills

(22)

Artificial colorant

(76)

2:1 AV block

Organic compound

(77)

Bradycardia

Byproduct of
incomplete
combustion

(78),
(79)

Abnormal heart
looping
Tachycardia
Decreased stroke
volume
Retene

Pericardial edema
Reduced blood flow
Enlarged atria with
thinner walls
Reduced ventricle
size
Underdevelopment
of bulbus arteriosus

Tartrazine

Pericardial edema
Bradycardia

Terodiline

HN

Tetrachlorodibenzo-paradioxin (TCDD)

Decrease in overall
size of heart
Defects in AV valves
Pericardial edema
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Trichloroacetate

Pericardial edema

Chlorination of
drinking water

(80)

Triclosan

Pericardial edema

Personal care
products;
antibacterial and
antifungal agent

(81)

Triphenyl Phosphate
(TPP)

Blockage of cardiac
looping

Flame retardants;
aryl phosphate ester

(82),
(83)

Pericardial edema

O
O

O
P

Bradycardia

O

Zirconia Oxide
nanoparticles

Pericardial edema

Bioceramic metal
compound

(84)

𝛼-Bisabolol

Pericardial edema

Personal care
products and
pharmaceuticals

(85)

Insecticide

(20)

Bradycardia
Thrombosis
Hemorrhage
Increased SV-BA
distance
Cardiac arrhythmia
λ-cyhalothrin

Pericardial edema
O
F

F

F
O

Cl

O

N
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Table 1. Environmental toxins related to congenital heart disease highlighted in
this study. Toxins are listed alphabetically. Tachycardia and bradycardia are
abnormally rapid and slow heart rates, respectively. Pericardial edema is the
accumulation of excess fluid in the pericardial sac surrounding the heart, putting
pressure on the heart and affecting its ability to contract properly. Arrhythmias are
abnormal or irregular heartbeats, occurring when the electrical circuit of the heart is
malfunctioning. Stroke volume (SV) is the amount of blood pumped by the ventricle
in one contraction. The bulbus arteriosus (BA) is the outflow tract component of the
zebrafish heart that maintains constant blood flow to the gills, and the sinus venosus
(SV) is the inflow tract of the heart, delivering blood into the atrium. A 2:1
atrioventricular (AV) block is a conduction block in the heart that prevents cardiac
impulse transmission between the atria and ventricle. A thrombosis is a blood clot in
the circulatory system. A hERG (human ether-á-go-go gene) is a potassium channel
gene that, if disrupted, can cause lethal arrhythmias.
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DISCUSSION
I. ccdc141 gene expression
Through the use of in situ hybridization, we observed ccdc141 expression in the yolk
syncytial layer (YSL) at 50% epiboly stage; mesoderm at bud stage; polster and paraxial
mesoderm at 3s stage; anterior lateral plate mesoderm (ALPM) and somites at 10s stage; heart
and somites at 26 hpf stages; and heart, somites, and head in 36 hpf stage. These findings
indicate that variants/mutations of ccdc141 could be involved in the development of CHDs and
are important for understanding the role of ccdc141 in heart development because the location(s)
and time(s) at which a gene is expressed provide insight into its function. For example, if a gene
is expressed only during development and not in adult organisms, the gene likely only functions
in development; or if a gene is not expressed in a tissue, it is unlikely to serve a function in that
tissue.
Due to time constraints, we were unable to observe the 16s, 22s, 48 hpf and 72 hpf stages
as originally planned. Studies of the 16s and 22s stages would provide more information on
ccdc141 expression throughout the segmentation period where growth is rapidly occurring, as
the presented results provide data on only the first half of the period. These stages correspond to
a specific time period in cardiac development: 16s when cardiomyocytes are undergoing angular
movement to perform cardiac fusion and 22s when cardiac fusion has completed. Analysis of the
48 hpf stage would provide information on the hatching period, and the 72 hpf stage would offer
data on expression at the last stage of development before the start of the larval period, when
cardiac trabeculation is starting.
These results lay a foundation upon which further study of the role of ccdc141 in
development can be performed. We found that ccdc141 is expressed in both cardiac

45

primordium/ALPM mesoderm and in neural tissue. Expression in the neural tissue is consistent
with previous studies implicating ccdc141 in neuronal migration; thus, ccdc141 might serve a
similar function in the ALPM, which is undergoing collective migration towards the midline of
the zebrafish to fuse and create a single heart. We also found that ccdc141 is expressed in the
heart and somite tissue, which will become trunk muscle, indicating that ccdc141 may be
important for musculoskeletal development as well. In light of this information, future ISH
experiments could be conducted to determine ccdc141 expression in the larval, juvenile, and
adult periods of development. This would allow for a more thorough and detailed view of
expression throughout the entire lifespan and, together with the presented data, would help
determine if ccdc141 is expressed and functioning only in development, or if it plays a role in
adulthood as well. Results on function can then be extrapolated to humans, as ccdc141 in
zebrafish is orthologous to that in humans and thus may retain the same function. This use of
zebrafish as model organisms is a key component in research because it bypasses many of the
ethical concerns that come with research on humans, which allows us to study diseases and test
possible treatments in a practical way.

II. Toxicology
Through extensive research, a table of 44 known cardiotoxins was compiled to be used in
the publication of a review chapter, written by the Bloomekatz lab, regarding the genetic and
environmental components of CHDs (86). The mechanism by which the environmental toxins
presented induce cardiotoxicity is unknown. In line with the research on the role of toxins in
developmental abnormalities more broadly, we see that the severity of abnormal cardiac
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phenotypes is dependent on both the duration and concentration of exposure, as well as the
developmental stage at which exposure occurs.
Distinct types and classes of chemicals produce similar phenotypes. For example,
polycyclic aromatic hydrocarbons (PAHs), like phenanthrene, pyrene, and benzo-a-pyrene,
disrupt the aryl hydrocarbon receptor (AHR) pathway. AHR is important transcription factor in
the regulation of toxicity in cells. PAHs act as ligands for AHR, and upon binding, can be
bioactivated to produce toxic metabolites (87). Phenotypes typical of PAHs include elongated
hearts and misplaced heart chambers. Pesticides, insecticides, and fungicides also produced
similar phenotypes; nearly all of these compounds result in pericardial edema, bradycardia, or
tachycardia. In all of the toxins presented, tachycardia, bradycardia, and edema were the most
common phenotypes.
It is my hope that this table can be used as an at-a-glance reference of environmental
toxicants that contribute to the development of CHD, as well as a basis for further studies. In
combining the two parts of my thesis, an interesting line of experimentation could involve
analyzing the connection between ccdc141 and environmental toxins in CHDs. For example,
determining if ccdc141 expression through ISH during development is disrupted in zebrafish
embryos exposed to the cardiotoxins presented in this work. Lastly, future experiments could be
performed to determine what correlation, if any, exists between toxicant exposure and normal
expression of ccdc141.
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